Literature DB >> 21530697

Induced malignant genome reprogramming in somatic cells by testis-specific factors.

Jin Wang1, Anouk Emadali, Aurore Le Bescont, Mary Callanan, Sophie Rousseaux, Saadi Khochbin.   

Abstract

Germline cell differentiation is controlled by a specific set of genes whose expression is tightly locked into the repressed state in somatic cells. Large-scale epigenome alterations, now evidenced in nearly all cancers, lead to aberrant activation of these normally silenced genes, as attested by the many reports describing the expression of testis-specific factors, known as cancer-testis genes, in various cancer cells. Here, based on the literature, we argue that off-context activity of some of the testis-specific epigenome regulators can reprogram the somatic cell epigenome toward a malignant state by favoring self-renewal and sustaining cell proliferation under stressful conditions, thereby constituting a major oncogenic mechanism. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21530697     DOI: 10.1016/j.bbagrm.2011.04.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

Review 1.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Authors:  Pierre G Coulie; Benoît J Van den Eynde; Pierre van der Bruggen; Thierry Boon
Journal:  Nat Rev Cancer       Date:  2014-02       Impact factor: 60.716

Review 2.  Reprogramming of gastrointestinal cancer cells.

Authors:  DyahLaksmi Dewi; Hideshi Ishii; Naotsugu Haraguchi; Shimpei Nishikawa; Yoshihiro Kano; Takahito Fukusumi; Katsuya Ohta; Susumu Miyazaki; Miyuki Ozaki; Daisuke Sakai; Taroh Satoh; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Journal:  Cancer Sci       Date:  2012-01-17       Impact factor: 6.716

3.  microRNA-based cancer cell reprogramming technology.

Authors:  Shimpei Nishikawa; Hideshi Ishii; Naotsugu Haraguchi; Yoshihiro Kano; Takahito Fukusumi; Katsuya Ohta; Miyuki Ozaki; Dyah Laksmi Dewi; Daisuke Sakai; Taroh Satoh; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

4.  Receptor-Independent Ectopic Activity of Prolactin Predicts Aggressive Lung Tumors and Indicates HDACi-Based Therapeutic Strategies.

Authors:  Aurore Le Bescont; Anne-Laure Vitte; Alexandra Debernardi; Sandrine Curtet; Thierry Buchou; Jessica Vayr; Aurélien de Reyniès; Akihiro Ito; Philippe Guardiola; Christian Brambilla; Minoru Yoshida; Elisabeth Brambilla; Sophie Rousseaux; Saadi Khochbin
Journal:  Antioxid Redox Signal       Date:  2014-03-06       Impact factor: 8.401

5.  Oocyte-specific linker histone H1foo is an epigenomic modulator that decondenses chromatin and impairs pluripotency.

Authors:  Koji Hayakawa; Jun Ohgane; Satoshi Tanaka; Shintaro Yagi; Kunio Shiota
Journal:  Epigenetics       Date:  2012-08-07       Impact factor: 4.528

6.  Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.

Authors:  Anouk Emadali; Sophie Rousseaux; Juliana Bruder-Costa; Claire Rome; Samuel Duley; Sieme Hamaidia; Patricia Betton; Alexandra Debernardi; Dominique Leroux; Benoit Bernay; Sylvie Kieffer-Jaquinod; Florence Combes; Elena Ferri; Charles E McKenna; Carlo Petosa; Christophe Bruley; Jérôme Garin; Myriam Ferro; Rémy Gressin; Mary B Callanan; Saadi Khochbin
Journal:  EMBO Mol Med       Date:  2013-07-04       Impact factor: 12.137

7.  Cancer hallmarks sustained by ectopic activations of placenta/male germline genes.

Authors:  Sophie Rousseaux; Jin Wang; Saadi Khochbin
Journal:  Cell Cycle       Date:  2013-07-11       Impact factor: 4.534

8.  Distinct distribution of ectopically expressed histone variants H2A.Bbd and MacroH2A in open and closed chromatin domains.

Authors:  Elena S Ioudinkova; Ana Barat; Andrey Pichugin; Elena Markova; Ilya Sklyar; Iryna Pirozhkova; Chloe Robin; Marc Lipinski; Vasily Ogryzko; Yegor S Vassetzky; Sergey V Razin
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

9.  Meta-analysis of clinical data using human meiotic genes identifies a novel cohort of highly restricted cancer-specific marker genes.

Authors:  Julia Feichtinger; Ibrahim Aldeailej; Rebecca Anderson; Mikhlid Almutairi; Ahmed Almatrafi; Naif Alsiwiehri; Keith Griffiths; Nicholas Stuart; Jane A Wakeman; Lee Larcombe; Ramsay J McFarlane
Journal:  Oncotarget       Date:  2012-08

10.  H2A.B is a cancer/testis factor involved in the activation of ribosome biogenesis in Hodgkin lymphoma.

Authors:  Xuanzhao Jiang; Jiayu Wen; Elizabeth Paver; Yu-Huan Wu; Gege Sun; Amanda Bullman; Jane E Dahlstrom; David J Tremethick; Tatiana A Soboleva
Journal:  EMBO Rep       Date:  2021-07-19       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.